- Standalone
- Bi-Modal
- Tri-Modal
- Others
Single-Photon Emission Computed Tomography Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type (standalone, bi-modal, tri-modal, others ), by application (medical industry, mechanical industry, others), by distribution channel (hospitals, diagnostic imaging centers, ambulatory surgical centers) and regions. This report studies global single-photon emission computed tomography market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. A Single Photon Emission Computed Tomography (SPECT) scan is a medical imaging technique that shows how blood flows to tissues and organs. A single photon emission computed tomography (SPECT) scan integrates two technologies which consists of computed tomography (CT) and a radioactive material (tracer). The tracer allows the doctors to see how blood flows to tissues and organs. A radioactive-labeled pharmaceutical (radiopharmaceutical) is administered to a patient. The chemical that is radiolabeled, meaning it emits gamma rays that can be detected by the scanner. The computer collects the information emitted by the gamma rays and translates them into two-dimensional cross-sections. These cross-sections can be added back together to form a 3D image of your brain. In October 2017, Siemens Healthineers unveils new software features designed to bring advanced clinical capabilities to the Biograph Vision as well as the company's established Biograph mCT and Biograph mCT Flow PET/CT systems
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increase in the prevalence of chronic disorders, adoption of advanced treatment options, rising disease awareness levels among the patients, growing geriatric population, are expected to drive the growth of single-photon emission computed tomography market. However, some of the reasons such as huge capital investments, shorter half-life of radioisotopes and reimbursement issues are expected to hamper the growth of the single photon emission computed tomography (SPECT) market. Product recalls is another factor that is creating a negative impact on the worldwide market for SPECT which is facing challenges in terms of revenue growth.
North America single photon emission computed tomography (SPECT) market is expected to dominate the revenue share due to high adoption of advanced technologies and increase in the prevalence of chronic disorders. High adoption of cutting-edge technologies, sophisticated healthcare infrastructure are expected to create demand for SPECT market in this region. However, Asia-Pacific single photon emission computed tomography (SPECT) market is expected to grow further due to developing infrastructure in case of research, increasing patient pool, and increasing awareness about the chronic disorders among the patients.
Latin America
Europe
Asia Pacific
Middle East
North America
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
[urltag url='request-table-of-content']